Skip to content

Advanced cannabinoid scientific platform at MaRS

Discovery District Toronto

Who We Are

Global commercialization strategy with diversified & high margin income streams across 12+ countries.

Comprehensive commercial portfolio
Consumer, medical cannabis and cannabinoid supply chain

Multinational sales with international footprint
USA, Canada, Europe and LATAM

Revenue generation and scale up phase
3 consecutive Q-Q growth of minimum 30%

Proven scientific platform, including R&D, pre-clinical and clinical infrastructure in Canada

Cannabinoid drug development pipeline
30+ advanced commercial SKUs + pharmaceutical pipeline

World-renowned collaborations
with leading Canadian academic and clinical institutions

JLABS @ Toronto, Johnson & Johnson Innovation Centre
R&D headquarters in the MaRS Discovery District

Established and environmentally sustainable low-cost vertical integration in Colombia

Two Colombian majority-owned subsidiaries
cultivation footprint of 480,000 sq feet with industrial extraction capacity

World-renowned collaborations
with leading Canadian academic and clinical institutions

Organic and sustainable cultivation
ranked highest amongst global cannabis companies in a corporate sustainability assessment – issued by S&P Global in 2020

Our Portfolio

The Company actively collaborates with leading Canadian academic and medical institutions.

Avicanna has established an industry-leading scientific platform including advanced R&D and clinical development which has led to the commercialization of over twenty products across four main market segments:

Commercial Stage
Medical Cannabis and Wellness Products

Commercial Stage
CBD Dermacosmetics Consumer Retail Products*

In Development and Registration Stage
Pharmaceutical Pipeline

Commercial Stage
Cannabinoid API & Seeds

Industry Leading Scientific Platform

Setting the Standard in the Cannabinoid Industry on Advanced and Evidence-Based Products

Established Research & Development Platform

Setting the Standard in the Cannabinoid Industry with Advanced and Evidence Based Product

R&D headquarters at JLABS @ Toronto, Johnson & Johnson Innovation Centre in the MaRS Discovery District Drug development pipeline, including sustained release tablets, transdermal patches and nano participle formulations

30+

Proprietary Commercial Products

10+

Scientists

7+

Canadian Government research grants awarded since 2020

8+

Pending Patents

4+

4 Health Canada issued cannabis research licenses issued to Avicanna or institutional collaborators over the
past 4 years

World-Class Collaborations

R&D and Clinical Partnerships Over the Past 4 Years

World-Class Collaborations

R&D collaborations with world-class academic and clinical institutes

Avicanna counts with collaborations with world-class academic and clinical institutes Including 4 Health Canada cannabis R&D licenses issued to Avicanna and its academic collaborators.

MaRS Discovery
District

University Health
Network

Hospital of
Sick Children

University of
Guelph

JLABS @ Toronto

University of
Toronto

Sunnybrook Health
Science Centre

Clinical Development

Setting the Standard in the Cannabinoid Industry on Advanced and Evidence-Based Products

08.08.2021

Products & Pipeline

Serving the Global Marketplace with Proprietary Advanced Cannabinoid-Based Products